Claris Bio
Drug DiscoveryWebsite
Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. The company's technology creates a recombinant hepatocyte growth factor that accelerates the healing proces...
Valuation
$163.4M
Market implied
Share Price
N/A
Total Raised
$153.6M
Last Round
Later Stage VC (Series A)
Jan 2024
Latest Funding Round
Later Stage VC (Series A)
Jan 4, 2024
$54.5M
raised
Investors
+4 other investors